scientific program • symposia - American Society for Reproductive ...

SCIENTIFIC PROGRAM • INTERACTIVE SESSIONS
Monday, October 17, 2011 1:15 pm – 2:15 pm
Meet the Director
NICHD: YOUR CHANCE TO MEET THE DIRECTOR
Louis V. DePaolo, Ph.D. (Chair)
Eunice Kennedy Shriver National Institute of Child Health and Human
Development
Alan E. Guttmacher, M.D.
National Institute of Child Health and Human Development
Monday, October 17, 2011 1:15 pm – 2:15 pm
Menopause Day Luncheon Interactive Session (Ticketed)
MENOPAUSAL ANDROGEN REPLACEMENT: A GLOBAL VIEW
Joint Session presented by the Menopause Special Interest Group and the
International Menopause Society
John E. Buster, M.D. (Chair)
Women and Infants Hospital
Nicholas Panay, B.Sc., M.B.B.S.
Imperial College Healthcare NHS Trust
Bruce R. Carr, M.D.
University of Texas Southwestern Medical Center
Needs Assessment and Description
Most physicians consider menopausal decreased sexual
desire (Hypoactive Sexual Desire Disorder, [HSDD] ICD#
799.81) to be intractable and difficult to treat. In their
practices, they avoid asking about this problem. Few
physicians are trained to identify and manage declining
sexual desire in aging women. They do not understand its
link to mood elevating drugs and decreasing androgen
production, nor appreciate the adverse psychological
impact and dysfunctional effects on partners and families.
This presentation, directed to physicians and allied health
practitioners who care for aging women, reviews recent
knowledge and innovation on the endocrinology of HSDD
and its treatment. The presentation fills this knowledge gap
and will significantly enhance the skills of learners to care for
this very common and neglected problem.
Learning Objectives
At the conclusion of this session, participants should be able
to:
1. Describe the endocrinology and pathophysiology of
HSDD at it relates to woman’s aging, genetics, declining
androgen production, and linkages to other disorders of
sexual functioning.
Room 240 A/B
Room 230 A/B
83
ACGME COMPETENCY
Systems-based Practice
2. Identify and manage drugs associated with HSDD in both
women and men.
3. Manage administration of transdermal estradiol and
testosterone in the managment of HSDD.
ACGME COMPETENCY
Medical Knowledge
Patient Care
TEST QUESTION:
After participating in this session, I will do the following in my
practice:
A. Do not ask about sexual desire in postmenopausal
women who have undergone oophorectomy.
B. Prescribe SSRI medications to postmenopausal women
who are depressed over declining sexual desire.
C. Prescribe vaginal estradiol, transdermal estradiol and
transdermal testosterone to a 50-year-old
oophorectomized woman who is complaining of lost
sexual desire.
D. Prescribe oral estradiol and methyltesterone to a woman
who underwent oophorectomy and suffered a postoperative
episode of deep vein thrombosis.
E. Prescribe oral conjugated estrogens to postmenopausal
women as first choice for decreased sexual desire.
F. Not applicable to my area of practice.